Hint mode is switched on Switch off
For swift navigation between sections

International bonds: Bausch Health Companies, 7.25% 15jul2022, USD
USU9098VAJ18

  • Placement amount
    550,000,000 USD
  • Outstanding amount
    550,000,000 USD
  • Minimum Settlement Amount
    2,000 USD
  • ISIN RegS
    USU9098VAJ18
  • CFI RegS
    DBFUGR
  • FIGI RegS
    BBG001KFFG09
  • SEDOL
    B58Q929
  • Ticker
    BHCCN 7.25 07/15/22 REGS

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Bond is not traded; the issue is redeemed
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
Customize fields in the table
Found:
Show all fields
* Data is not available within the selected subscription
Quotes from market participants are indicative

Stock exchange and OTC quotes

Issue information

Profile
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc., before Biovail Corporation) is a specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. It operates in five business segments: U.S. Neurology and ...
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc., before Biovail Corporation) is a specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. It operates in five business segments: U.S. Neurology and Other, U.S. Dermatology, Canada and Australia, Branded Generics - Europe and Branded Generics -Latin America. On December 12, 2011, it acquired assets of the Ortho Dermatologics division of Janssen Pharmaceuticals, Inc. (Janssen). On December 16, 2011, it acquired the dermatology business, Dermik, of Sanofi. On December 21, 2011, it acquired iNova, from Archer Capital, Ironbridge Capital and other minority management shareholders. On February 1, 2012, it acquired Probiotica Laboratorios Ltda. On February 3, 2012, it divested 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), and 5% fluorouracil cream, (5-FU). On March 12, 2012, it acquired a 19.9% interest in Pele Nova Biotecnologia S.A. In April 2012, it acquired Pedinol Pharmacal, Inc.
Volume
  • Placement amount
    550,000,000 USD
  • Outstanding amount
    550,000,000 USD
Nominal
  • Minimum Settlement Amount
    2,000 USD
  • Outstanding face value
    *** USD
  • Integral multiple
    *** USD
  • Nominal
    1,000 USD

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count fraction
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***
  • Early redemption date
    ***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Early redemption terms

***

Debt Servicing

Find Any Data on Any Bond in Just One Click

Full data on over 500,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

User-friendly and intuitive across multiple platforms

Get access

Identifiers

  • ISIN RegS
    ***
  • ISIN 144A
    ***
  • CUSIP RegS
    ***
  • CUSIP 144A
    ***
  • CFI RegS
    DBFUGR
  • CFI 144A
    DBFUGR
  • FIGI RegS
    BBG001KFFG09
  • FIGI 144A
    BBG001KFFBP3
  • WKN RegS
    A1ZJ83
  • WKN 144A
    A1GNGD
  • SEDOL
    B58Q929
  • Ticker
    BHCCN 7.25 07/15/22 REGS
  • Type of security by CBR
    ***

Bond classification

  • Registered
  • Coupon bonds
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
  • Trace-eligible

Restructuring

***

Registration is required to get access.